Teladoc Health insiders Arnnon Geshuri and Stephany Verstraete sold shares on September 3.
Teladoc Health insiders Arnnon Geshuri and Stephany Verstraete sold shares of the company on September 3, each at an average price of $7.16. Geshuri sold 1,795 shares, while Verstraete sold 2,083 shares, bringing their respective holdings to 44,914 and 48,843 shares. Following these transactions, Teladoc's stock rose to $7.44, with a market cap of $1.27 billion. Analysts project a -0.71 EPS for the year, with a consensus rating of "Hold."
September 04, 2024
13 Articles